From November 8-9, co-hosted by the International Society of Clinical Oncology and the Tumor Hyperthermia Committee of the China Anti-Cancer Association, and organized by the Shenzhen Anti-Cancer Association and Shenzhen Huaqiao Hospital, the 2024 First (Shenzhen) International Tumor Hyperthermia Conferenceand the China Anti-Cancer Association CACA
Hyperthermia Guideline Tour (Shenzhen Station)、and the founding meeting of the Tumor Hyperthermia Committee of the Shenzhen Anti-Cancer Association was grandly held in Shenzhen.
ChinaAcademy of EngineeringAcademician、China Anti-Cancer AssociationChairmanAcademician Fan Daiming，Royal Society of Medicine UK院Academician、International Society of Clinical Oncologyvice chairmanPresident Yang Daoke，American Academy of Microbiological SciencesAcademician、Shenzhen Third People's HospitalPresident Lu Hongzhouserved asconferenceHonorary Chairman，China Anti-Cancer Associationtumor hyperthermiaspecialized committeeChairmanProfessor Zheng Yingjuan、CSCOhyperthermiaspecialized committeeChairmanProfessor Xiao Shaowenjointly served asconferencechairman,Shenzhen Huaqiao HospitalVice President Dong Wenguang、ChinaMedical Doctor AssociationradiotherapyBranch Radiosurgery CommitteeChairmanProfessor Long Zhixiong、China Anti-Cancer Associationminimally invasive tumor treatmentCommittee ViceChairmanProfessor Tang Rijieserved asconferenceExecutive Chairman, fromUnited States、GermanyandChinaBeijing、Guangzhou、Shenzhen、Tianjin, Zhengzhou, etc.domestic20+ provinces and regions400overtumor hyperthermiarenowned experts in the field ofexpert、Shenzhen Anti-Cancer Associationtumor hyperthermiacommittee members and related fieldsexpertscholarattendedconference。
Opening Ceremony
conferenceExecutive Chairman、Shenzhen Huaqiao HospitalVice President Dong Wenguangas the host, first took the stage, introducedintroduced the attending leaders and guests, warmly welcoming participantsstatedand expressed hopes for thetumor hyperthermiafield's vigorousdevelopmentdevelopment. Opening with "light and heat" as symbols, emphasizedhe highlighted the importance of medical advances forlifehealth. pointed outtumor hyperthermiaasgreen treatmentapproach will hold a place on theIn the futuremedical crown and envisionedShenzhenaftertumorgreen treatmentfield achieving greaterachievements。
ShenzhenMunicipal Anti-Cancer AssociationChairmanShen Weixirepresenting the associationspeech, for thisconference's successful conveningstatedextended congratulations andmentioned，conferencewill focus ontumortreatment andcomprehensive treatmentthe latestachievements and clinical application，expert们sharedthe frontiers ofacademicreport and valuableexperience, will promotetumor hyperthermiain the field ofinnovationdevelopment。hopethrough thisconference, strengthening ties among peers and cooperation, jointly improvingtumorTreatment Outcomes, contributing wisdom and strength to the industry!
As the organizer, Shenzhen Huaqiao HospitalHu MingyanPresidenttook the stagespeech, expressed welcome to attending guests and gratitude, andstated，hyperthermiatechnologyafterShenzhen Huaqiao Hospitalhas been carried out for over a decade. 2014year,hospitalestablishment of "NationalclinicaltumorTreatment Demonstration Base," 2021, it became a "Nationaltumor hyperthermiaDemonstration Base." This year, hospital的tumor hyperthermiacenter welcomed a major upgrade, introducingCurrently, the most advanced in the nation,hyperthermiaequipment, such asShenzhen's first、domesticthe only one capable of both whole-bodyhyperthermiaand localhyperthermiaNRL-003type radiofrequencyhyperthermiasystematic, a new milestone in China'stumor hyperthermiafieldtechnologybreakthrough, fortumorwidelyand metastasis的patients，aftersurgery、radiotherapy、chemotherapyare all ineffective, whole-bodyhyperthermiatechnologycan serve as a veryeffectivetreatment ofapproach, relievingpatientssymptoms, improvingpatients的quality of life, prolongingpatientssurvival period。
conferenceHonorary Chairman、ChinaAcademy of EngineeringAcademician、China Anti-Cancer AssociationChairmanFan Daimingdelivered via video aopening speech, hementioned: "tumortreatment using physicalmethodshould be the mosteffective, whilehyperthermia是among whichvery important one. tumor tissueand normal human tissue have differenttemperaturetolerance. The body can tolerate47degrees of heat, whiletumorafter43度approximately的temperatureit can be eliminated. Through this temperature difference, we can treat.tumor hyperthermiadoes not seriously damage normal tissue!This treatment approach - temperaturecontroltechnologyis very important. ChinaChina has solved this well, especially in treatingintraperitonealtumor和ascitesproblems. hyperthermiahas demonstrated goodefficacy. For example, intraperitonealtumor，1ten thousand millilitersascitesmany have been cured through heat therapy!"。
American Academy of Microbiological SciencesAcademician、Shenzhen Third People's HospitalPresident Lu Hongzhoudelivered via videospeech，emphasizedIn the futuretumortreatment will be guided bystandardsspecialization andmultidisciplinarycooperation, hyperthermiaas a key treatmentapproachwill play an important role.
United KingdomRoyalAcademician、International Society of Clinical OncologyVice Chairman, First Affiliated Hospital of Zhengzhou UniversityhospitaltumorhospitalPresident Yang Daokespeech，sharedhisaftertumor hyperthermiafield insights, and detailedintroduced了hyperthermiaaftertumorunique role and three core advantages in treatmenttechnology：precisionhyperthermia, open-type whole-bodyhyperthermiaand advanced temperature monitoringtechnology。Meanwhilepointed outhyperthermiaaftertumorcurative, maintenance treatment, and improvingpatientsquality of lifeaspects的advantages, also particularlymentionedinterventional+hyperthermiainnovativenew model, forhyperthermiabringingnew breakthrough。Meanwhilementionedhyperthermiadue to no tissue tolerance limitations and no toxicity restrictions, can be performed in a widerwidelyrange, and has beeninternationalclinicaltumorassociation recognized as followingsurgery、radiotherapy、chemotherapy和immunetherapy, the "fifth majortumortreatmentapproach"，afterclinical中resultssignificantly, with broad prospects.
ChinaMedical Doctor Associationradiation射tumorTherapy Physicians Branch President, TianjinMedical UniversitytumorhospitalWang PingPresidentspeech，emphasized了tumor hyperthermiaas an emerging treatmentapproach, in reducingpatientssuffering and improvingquality of lifeplayed an important role.
conferencechairman,Chinaclinicaltumorsocietyhyperthermiaspecialized committeeChairman、Peking University Cancer HospitalProfessor Xiao Shaowenspeech, to attendingconferenceguestsstatedwarm welcome andgratitude, and对conferenceconvening ofstatedcongratulations.pointed out，tumor hyperthermiaas a combination of traditional and innovationtreatment ofapproach, has become a highly regardedFollowtreatment direction that can directly killtumor cells,and also enhancingchemotherapy和surgery的efficacy，Meanwhileand strengtheningpatients的immunityand improving treatment tolerance, reducing side effects from traditional treatmentside effects。
conferencechairman,China Anti-Cancer Associationtumor hyperthermiaspecialized committeeChairmanProfessor Zheng Yingjuanspeech, thanked all attendees, congratulatedShenzhenMunicipal Anti-Cancer Associationtumor hyperthermiaestablishment of the professional committee, andLike扬Vice President Dong Wenguangserved asChairman's significance, pointed outthis move forShenzhenhyperthermiathe cause ofdevelopmenthaving milestone significance.In addition, alsointroducedannounced the release of 'China Anti-Cancer AssociationCACAguidelines》 and nationwidelecture toursituation, andemphasizedShenzhenasinnovationopen city's uniqueadvantages和afterhyperthermiatechnologypromotion potential.
Under the joint witness of leaders and guests, conferencegrandly opened with a solemn and ceremonial opening ceremony. As the lights brightened, enthusiastic applause and expectant gazes marked this moment. The ceremony officially began as the host announcedconferencethe opening, with a warm atmosphere symbolizing thisconferencethe opening ofnot onlyas a new beginning and an industryinnovation and development's fresh starting point.
opening speechAfter the conclusion, conferenceentered professional topicshared, discussion, andexchangedsession.
Part One topic
Yang DaokeProfessorpresented 'ModernhyperthermiaDiscipline Formation and development' as the topic,speech，in-depthintroducedmodernhyperthermiadisciplinarydevelopmenthistory, analyzing itscancer treatmentimportant role.
Professor Xiao Shaowenon "hyperthermiacombined generadiotherapyafterhead and necktumor' was brilliantly explained, demonstratedthe latestresearchachievements。
Professor Zheng Yingjuanon "China Anti-Cancer AssociationCACAlecture tour：hyperthermiaapplication in brain glioma treatment and progress' as the theme, introduced了hyperthermiatechnologylatest applications in brain glioma treatment and progress，emphasizeditsclinicaladvantages。
Ge WeiProfessorin-depthdiscussedon "tumor microenvironmentimpact on treatment decisions, analyzinghyperthermia's key role.
Zheng RonghuiProfessoron "China Anti-Cancer AssociationCACAhyperthermiaguidelineslecture tour(the third section:temperature measurement and control, technology' as the topic, shared了hyperthermiaguidelinestemperature measurement and control intechnology, forhyperthermia的clinical applicationproviding reference.
Shen WeixiProfessoron "integrative Chinese and Western medicinenew approaches to diagnosing and treating diseasesprogress' as the topic, discussedintegrative Chinese and Western medicineafterhyperthermiaapplications, providingclinicaltreatment with new perspectives.
Professor Dou Yongchongon "CTunder guidanceI125 seed implantationtreatment of high-risk locationmalignanttumor' as the topic, explainedCTunder guidanceI125seed implantationtechnologyaftertumorapplications in treatment, demonstrateddemonstrated high-precision treatmentmethod。
Part Two topic
Wang FangjunProfessoron "tumor hyperthermia and interventionalablationrelated issuesdiscussed' as the topic, discussed了hyperthermia and interventionalablationaftertumorrole in treatment, andsharedshared practical application cases.
Zhou TaoProfessoron "Chinaadultpatientsparenteral and enteral nutritionclinical applicationguidelinesinterpretation' as the topic, interpretationthe latest nutrition applicationguidelines，emphasizednutritional support incancerpatientsduring treatment's key role.
Wang LigenProfessoron "radiation therapy and tumor hyperthermiacombined application' as the topicintroduced了radiation therapy and hyperthermialatest in combined applicationprogress, for radiationtumoropened up newnew direction。
Wang JianProfessoron "hyperthermia and tumor tissuestructural relationships' as the topic, analyzedhyperthermia对tumor tissuestructural impact, demonstrated了multidisciplinarycombined treatment approaches.
Germany的Dr. Robert GorterProfessoron "Hyperthermia as a major Tool in treating Cancer Patients successfully in a Non-Toxic Way" as the topicsharednon-toxicside effects的hyperthermiaaftercancer treatmentapplications, providingprovided attendees withinternationalperspective.
Professor Long Zhixiongon "tumornon-invasiveradiosurgeryablation treatmenttechnology" as the topicdemonstrated了non-invasiveradiosurgerytechnologyaftertumortreatment'sinnovationapplication, achievingsignificantlyresults.
Tang HongshengProfessoron "CACAperitonealtumorguidelinesgastrointestinal cancer sectioninterpretation' as the topic, interpretation了CACAperitonealtumorguidelines, providing standardized protocols for gastrointestinal cancer treatmentplan。
Yu JianProfessoron "hyperthermia的clinical application and progress' as the topic, demonstrated了hyperthermiaafterclinicallatest applications inprogress, bringing cutting-edge treatmenttechnology。
Professor Tang Rijieon "minimally invasivemethodsintraperitonealcatheter hyperthermic perfusionchemotherapy的clinical application' as the topic, introduced了minimally invasivemethodsintraperitonealcatheter hyperthermic perfusionchemotherapythe latestclinical applicationprogress. Thistechnologythroughminimally invasivemethod将chemotherapy drugsdirectly introduced intointraperitonealtumorsite and combined withhyperthermiaenhanced efficacy, effectivereducing systemicside effects, improving local control rate, providingintraperitonealtumor patientswith better treatment options.
Huang ZhenhuaProfessorpresented 'Deephyperthermiaaftertumorinresearchprogress" as the topicshareddeephyperthermiaaftertumortreatment'sresearchprogress，in-depthanalyzed deephyperthermiaafterimprovetumorlocal control rate and improvingpatientsprognosisapplication results. By combining different radiationchemotherapyapproach, deephyperthermiain various refractorytumordemonstrated promising treatment prospects.
Yin ChunzhuProfessoron "intraperitonealhyperthermic perfusionchemotherapymechanism and clinical application' as the key topicintroduced了intraperitonealhyperthermic perfusionchemotherapybiological mechanisms andintraperitonealcancerouseffusion and advanced-stageintraperitonealtumorinclinical application. Thistechnologythrough thermalchemotherapy drugsdirect perfusion, achievingintraperitonealtumor的efficienttargeted effects, expected tosignificantlyimprovingpatients的quality of life。
Nie DahongProfessorpresented 'Advancedcancer的minimally invasive treatment' as the topic, shared了minimally invasive treatmenttechnologyafteradvanced-stagecancerapplication in,introduced了In recent yearsafterintraperitonealendoscope,radiofrequency ablation and ultrasound-guidedminimally invasive interventiontechnology的development. Thesetechnologysignificantlyreducedsurgerytrauma, providing advancedtumor patientswith new treatment options, prolongingsurvival periodand improvingquality of life。
Li DingfengProfessorpresented 'Subcutaneous Implantablearterytargeted thermalchemotherapyaftertumortreatment'sapplication' as the topic, discussedsubcutaneous implantablearterytargeted thermalchemotherapytechnologyaftertumortreatment'spractical application and 其advantages. Through subcutaneous implantationcatheterand continuousarteryinfusionchemotherapy drugs, combined withhyperthermiaachieving betterprecision的tumorinhibitory effects, substantiallysignificantly improvedtumor patientstreatment compliance andquality of life。
United States的Dr. Dario Barros RodriguesProfessorfrominternationalperspective, presented 'Deep Hyperthermia Therapy" as the topicdiscusseddeephyperthermiain different types oftumorapplication in,sharedthetechnologyafterclinical researchlatest data in and successful cases, demonstrating deephyperthermiaafterimprovecancerTreatment Outcomespotential.
Jia JunProfessoron "tumor hyperthermiaaftertumorcomprehensive treatmentapplication in' as the topic, discussed了tumor hyperthermiaaftercomprehensive treatmentplanimportant role, emphasizedhyperthermia and radiotherapy、chemotherapy and immunesynergistic effects of therapies. JiaProfessor还sharedmultipleclinicalcases,demonstrated了hyperthermiaas adjuvant treatmentapproach的widelyapplication.
Professor Dong Wenguangon "tumor hyperthermiacombinedinterventional treatmentin mid-to-late stagemalignanttumortreatment'sapplication' as the topic, introducedthe combined therapy's role in prolonging mid-to-late stagetumor patientssurvival period and and alleviating symptoms.combined treatmenthelps multi-target attack ontumor cells, forpatientsproviding new treatmentoption。
conferenceclosing ceremony
finallyconferenceExecutive Chairman、Jinan University Affiliated Shenzhen Huaqiao HospitalVice President Dong Wenguang对conferenceconductedclosing speech。
This one-and-a-half-day First(Shenzhen)internationaltumor hyperthermiaconference于11月9eveningsuccessfully concluded. Along withtechnologycontinuouslyprogress andclinicalexperienceaccumulation, tumor hyperthermiaaftercancer treatmentpotential is increasingly evident.hyperthermianot onlycan and radiotherapy、chemotherapy, etc.traditional treatmentapproachcombined, can also and minimally invasive interventional treatmentjointly achieveprecision的individualizedplan, improvingpatients的quality of life。In the future, along withmultidisciplinarydeepened cooperation, tumor hyperthermia将aftercancer treatment的greenspecialization andprecisionplay a greater role, becomingpatientsquality of lifeimportant pillar, boostingtumortreatment field'sinnovation and development。